M. L. Simoons - Concepedia

Author

M. L. Simoons

Also Known As

Broer, DJ Dirk=Dick, M L Simoons, M SIMOONS, M Simoons, M. L. SIMOONS, M. L. Simoons, M. Simoons, M.L. Simoons, Maarten L Simoons, Maarten L. Simoons

Publications

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Netherlands Heart Institute Rotterdam University of Applied Sciences University of Ferrara

About

M. L. Simoons is an author at Erasmus University Rotterdam specializing in cardiology, cardiovascular disease, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	375
2	Emergency Medicine	9	9	382
3	Public Health	7	7	303
4	Health Sciences	3	3	80
5	Applied Physiology	3	3	80

M. L. Simoons

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group. M. L. Simoons, M. J. de Boer, Marcel J. van den Brand, Circulation	1994	245
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT Claudio Ceconi, K. Fox, W. Remme, Cardiovascular Research	2006	175
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart Mattie Lenzen, Lars Rydén, John Öhrvik, European Heart Journal	2006	167
Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey. John H. Alexander, Robert A Harrington, Robert H. Tuttle, The American Journal of Cardiology ThrombosisCardiovascular EpidemiologyCardiovascular DiseaseClinical EpidemiologyWorse Outcomes	1999	128
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI–SK study M. L. Simoons European Heart Journal	2002	101
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials Jasper J. Brugts, Toshiharu Ninomiya, Eric Boersma, European Heart Journal	2009	57
A comparison of methods of analysing exercise tests for diagnosis of coronary artery disease. Jaap W. Deckers, Benno J. Rensing, J G Tijssen, Heart Physical ActivitySt Segment DepressionCoronary Artery DiseaseAcute Myocardial InfarctionElectrophysiological Evaluation	1989	53
Coronary recanalization in acute myocardial infarction: immediate results and potential risks Patrick W. Serruys, Marcel van den Brand, T. E. H. Hooghoudt, European Heart Journal Endovascular TechniqueSeptember 1980SurgeryCoronary Artery DiseaseAcute Myocardial Infarction	1982	48
Rapid and accurate measurement of LV mass by biplane real-time 3D echocardiography in patients with concentric LV hypertrophy: Comparison to CMR☆ Sing‐Chien Yap, R.J.M. vanGeuns, Attila Nemes, European Journal of Echocardiography	2007	39
Estimated gain in life expectancy: A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction Hendrikus H. Boersma, M. J. van der Vlugt, Alfred Arnold, European Heart Journal Heart FailureReperfusion TherapyCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1996	36

Page 1